XML 52 R40.htm IDEA: XBRL DOCUMENT v3.24.1.u1
EQUITY (Tables)
 3 Months Ended
Mar. 31, 2024
Equity [Abstract]  
Schedule of Warrants Outstanding and Exercisable The following table summarizes the status of warrants and related transactions:
Non-Derivative (Equity) Warrants (1)
Derivative Liabilities Warrants
Total Number of WarrantsWeighted - Average Exercise Price
Balance as of January 1, 2024
49,068,63637,862,92286,931,558$1.12 
Granted2,050,000 — 2,050,000 $0.97 
Balance as of March 31, 2024
51,118,63637,862,92288,981,558$1.12 
Exercisable as of March 31, 2024
49,083,63637,862,92286,946,558$1.12 
(1)In February 2024, there were 1,800,000 warrants issued in connection with the Debt Exchange. Refer to Note 9 - Debt for more information.
Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions The following assumptions were used for the calculation at date of issuance:
Weighted average stock price$0.93
Weighted average expected stock price volatility76.5%
Expected annual dividend yield0%
Weighted average expected life of warrants
3.1 years
Weighted average risk-free annual interest rate4.1%
Weighted average grant date fair value$0.48
Summary of Stock Options Outstanding The following table summarizes the status of stock options and related transactions:
Number of Stock OptionsWeighted-Average Per Share Exercise Price
Issued and Outstanding as of January 1, 202427,653,184 $1.40 
Granted1,220,000 $0.70 
Exercised
(3,333)$0.60 
Cancelled/forfeited/expired(273,166)$1.77 
Issued and Outstanding as of March 31, 202428,596,685 $1.36 
Exercisable as of March 31, 202415,966,391 $1.75 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following assumptions were used for the calculation at date of grant:
Three Months Ended March 31,
20242023
Weighted average stock price$0.70$0.60
Weighted average expected stock price volatility77.1%77.4%
Expected annual dividend yield0%0%
Weighted average expected life5.1 years6.2 years
Weighted average risk-free annual interest rate4.3%3.7%
Weighted average grant date fair value$0.46$0.42
Nonvested Restricted Stock Shares Activity The following table summarizes the status of restricted stock and related transactions:
Number of Restricted Subordinate Voting Shares
Unvested restricted stock as of January 1, 20241,861
Unvested restricted stock as of March 31, 20241,861
Components of Share-based Compensation Expense
The components of share-based compensation expense are as follows:
Three Months Ended March 31,
20242023
Stock options$1,355 $1,596 
Restricted stock1 200 
Warrants168 515 
Total share-based compensation expense$1,524 $2,311